Inhibitory effects of compound sophora and disodium cantharidinate and vitamin B6 injections on the activity of cytochrome P450 enzymes in human liver microsomes
Xiao-jun CAI,Kai HUANG,Hui-zhu SONG,Hao WEN,Yuan HONG
DOI: https://doi.org/10.13699/j.cnki.1001-6821.2017.21.017
2017-01-01
Abstract:Objective To evaluate the inhibitive effects of disodium cantharidinate and vitamin B6 and compound sophora injections on 7 main cytochrome P450 (CYP450) isoforms in human microsomes in vitro for predicting the drug-drug interactions in clinical application.Methods Different concentrations of test disodium cantharidinate and vitamin B6 and compound sophora injections were incubated with human microsomes.phenacetin,bupropion,amodiaquine,(S)-mephenytoin,dextromethorphan,midazolam,testosterone were used as the substrates of CYP1A2,CYP2C9,CYP2C19,CYP2D6,CYP3A4-M,2B6,2C8 and CYP3A4-T,respectively.After the co-incubation,the metabolite of each substrate was analyzed by LC-MS/MS assay and then hemi-inhibitory concentration (IC50) was calculated.Results IC50 values(＞ 10 mg) of disodium cantharidinate and vitamin B6 were totally exceed its daily-dose (0.1-0.5 mg).IC50 values of compound sophora injection on CYP1A2,2D6,2C8,2C19 were 15.2,10.3,21.1 and 21.1 mL,respectively,which were less than or near to its daily-dosage.However,compound sophora injection's IC50 values on CYP2B6,2C9,3A4-M and 3A4-T were 63.5,72.0,95.5,92.5mL,which were much higher than its daily-dosage (20 mL).Conclusion Disodium Cantharidinate and vitamin B6 showed no inhibition on 7 main CYP450 isoforms in vitro at clinical normal dosage,while the inhibitory effects of compound sophora injection on the activities of CYP1A2,2D6,2C8,2C19 were strong and medium,respectively,but without inhibitory effect on the activities of other P450 isoforms.So,drug-drug interaction induced by inhibition of CYP450 enzymes should be paid more attention when compound sophora injection is used intravenously for therapy.